Metformin: The potential shield against long Covid

A new ray of hope

Metformin, a well-known anti-diabetes drug, could reduce the chances of developing long Covid, according to a recent study.

A promising study

The study found that metformin could reduce the risk of long Covid by 40% in patients who tested positive for Covid-19. The study involved more than 1 patients, showing promising results.

Limits and implications

Although the results are promising, metformin has not yet been tested on people who already have long Covid. Moreover, other drugs, such as ivermectin and fluvoxamine, have not been shown to be effective in preventing long Covid.